Design Therapeutics(DSGN)
$10.47-0.11 (-1.04%)
DSGN
Design Therapeutics earnings date
$10.47
At close:-0.11 (-1.04%)
Want to see DSGN full AI Analyst Report?
Design Therapeutics (DSGN) Q2 2026 Earnings Report
107 Followers
DSGN Q2 2026 EPS Results
- Actual EPS
- -$0.32
- Consensus EPS
- -$0.34
- Beat/Miss
- Beat by +$0.02
- One Year Ago EPS
- -$0.34
DSGN Q2 2026 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/03/2026
- Time
- Before Open
- Conference Call
- Monday, August 3, 2026
DSGN Upcoming Earnings
Design Therapeutics's next earnings date is estimated for March 15, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DSGN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 15, 2027 | 2026 (Q4) | -0.40- | -0.27 | ― | ― |
| Nov 04, 2026 | 2026 (Q3) | -0.34-0.32 | -0.3 | -6.67% (-0.02) | |
| Aug 03, 2026 | 2026 (Q2) | -0.34-0.32 | -0.34 | 5.88% (+0.02) | |
| Apr 28, 2026 | 2026 (Q1) | -0.33-0.29 | -0.31 | 6.45% (+0.02) | |
| Mar 09, 2026 | 2025 (Q4) | -0.35-0.27 | -0.24 | -12.50% (-0.03) | |
| Nov 05, 2025 | 2025 (Q3) | -0.34-0.30 | -0.23 | -30.43% (-0.07) | |
| Aug 07, 2025 | 2025 (Q2) | -0.33-0.34 | -0.21 | -61.90% (-0.13) | |
| May 07, 2025 | 2025 (Q1) | -0.28-0.31 | -0.2 | -55.00% (-0.11) | |
| Mar 10, 2025 | 2024 (Q4) | -0.27-0.24 | -0.21 | -14.29% (-0.03) | |
| Nov 07, 2024 | 2024 (Q3) | -0.24-0.23 | -0.28 | 17.86% (+0.05) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

